J. Kim

发表

Synergy of circulating miR-212 with markers for cardiovascular risks to enhance estimation of atherosclerosis presence

H. Jeong, Jei Kim, S. H. Lee, 2017, PloS one.

Relationships between Endogenous Estrogen and the Risk Factors for Vascular Disease

H. Jeong, H. Song, Jei Kim, 2011 .

Promoter methylation changes in ALOX12 and AIRE1: novel epigenetic markers for atherosclerosis

J. Issa, J. Jelinek, S. Kwon, 2020, Clinical Epigenetics.

Promoter methylation status of VEGF receptor genes: A possible epigenetic biomarker to anticipate the efficacy of intracellular-acting VEGF-targeted drugs in cancer cells

Young Woo Park, H. Jeong, H. Song, 2012, Epigenetics.

Aging and DNA Methylation

J. Issa, J. Kim, Jei Kim, 2009 .

Hypomethylation in MTNR1B: a novel epigenetic marker for atherosclerosis profiling using stenosis radiophenotype and blood inflammatory cells

J. Issa, J. Jelinek, J. Cha, 2023, Clinical Epigenetics.

The expression of VEGF receptor genes is concurrently influenced by epigenetic gene silencing of the genes and VEGF activation

Seung-Moo Noh, J. Y. Kim, I. Song, 2009, Epigenetics.

Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence.

J. Issa, J. Jelinek, P. Goldschmidt-Clermont, 2007, Biochimica et biophysica acta.

Decreased efficacy of drugs targeting the vascular endothelial growth factor pathway by the epigenetic silencing of FLT1 in renal cancer cells

J. Jelinek, S. H. Lee, J. Kim, 2015, Clinical Epigenetics.

Decreased efficacy of drugs targeting the vascular endothelial growth factor pathway by the epigenetic silencing of FLT1 in renal cancer cells

J. Jelinek, H. Jeong, S. H. Lee, 2015, Clinical Epigenetics.